Notable Upgrades: Splunk, Inc. (SPLK), Celladon (CLDN), salesforce.com (CRM), Globant S.A. (GLOB), Impax Laboratories (IPXL)

Analysts at Piper Jaffray are out with a report this morning upgrading shares of Splunk, Inc. (SPLK) with an ‘Overweight‘ from ‘Neutral‘ rating. The firm set its price target at $77. Splunk Inc. shares have a forward P/E of 218.27 and t-12 price-to-sales ratio of 16.69. EPS for the same period is ($1.81). In the […] View the full post at: Notable Upgrades: Splunk, Inc. (SPLK), Celladon (CLDN), salesforce.com (CRM), Globant S.A. (GLOB), Impax Laboratories (IPXL) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock